MDT

85.34

-1.11%↓

A

112.28

-1.01%↓

VEEV

169.84

-3.51%↓

HQY

81.94

-1.4%↓

PHR.US

8.2

-2.73%↓

MDT

85.34

-1.11%↓

A

112.28

-1.01%↓

VEEV

169.84

-3.51%↓

HQY

81.94

-1.4%↓

PHR.US

8.2

-2.73%↓

MDT

85.34

-1.11%↓

A

112.28

-1.01%↓

VEEV

169.84

-3.51%↓

HQY

81.94

-1.4%↓

PHR.US

8.2

-2.73%↓

MDT

85.34

-1.11%↓

A

112.28

-1.01%↓

VEEV

169.84

-3.51%↓

HQY

81.94

-1.4%↓

PHR.US

8.2

-2.73%↓

MDT

85.34

-1.11%↓

A

112.28

-1.01%↓

VEEV

169.84

-3.51%↓

HQY

81.94

-1.4%↓

PHR.US

8.2

-2.73%↓

Search

Guardant Health Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

91.19 -1.12

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

90.73

Max

94.99

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-36M

-128M

Pardavimai

16M

281M

Pelnas, tenkantis vienai akcijai

-0.5

Pelno marža

-45.684

Darbuotojai

2,490

EBITDA

-37M

-119M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+43.68% upside

Dividendai

By Dow Jones

Kitas uždarbis

2026-04-29

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-2.3B

11B

Ankstesnė atidarymo kaina

92.31

Ankstesnė uždarymo kaina

91.19

Naujienos nuotaikos

By Acuity

50%

50%

163 / 349 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

Guardant Health Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-04-01 22:56; UTC

Svarbiausios naujienos

Australian PM Set To Announce Interest-Free Loans For Businesses, Farmers

2026-04-01 20:50; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Extends Deadline on Tender Offer to Acquire Arcellx

2026-04-01 23:55; UTC

Rinkos pokalbiai

Gold Rises on Hopes for Early End to U.S.-Iran Conflict -- Market Talk

2026-04-01 23:43; UTC

Rinkos pokalbiai

Nikkei May Rise on Continued Hopes for U.S. Ending Iran War -- Market Talk

2026-04-01 23:23; UTC

Svarbiausios naujienos

South Korea Consumer Inflation Accelerates on Mideast Energy Shock -- Update

2026-04-01 23:07; UTC

Uždarbis

Shake Shack Leans on Loyalty Program and Tech to Drive Growth -- Barrons.com

2026-04-01 23:02; UTC

Svarbiausios naujienos

South Korea Consumer Inflation Accelerates on Mideast Energy Shock

2026-04-01 23:00; UTC

Svarbiausios naujienos

S Korea Mar CPI +0.3% on Month; +0.6% Forecast

2026-04-01 23:00; UTC

Svarbiausios naujienos

S Korea Mar Core CPI +2.2% on Year, +0.1% on Month

2026-04-01 23:00; UTC

Svarbiausios naujienos

S Korea Mar CPI +2.2% on Year; +2.4% Forecast

2026-04-01 22:39; UTC

Uždarbis

Nike Can't Fix Its China Problem and That's Tanking Its Stock -- Update

2026-04-01 22:08; UTC

Rinkos pokalbiai

KKR BDC Joins Others in Capping Withdrawals at 5% -- Market Talk

2026-04-01 22:00; UTC

Svarbiausios naujienos

Mideast War Rekindles Asia Inflation Risk, Says DBS Chief Economist -- Interview

2026-04-01 22:00; UTC

Svarbiausios naujienos

DBS Chief Economist: Rate Hikes Seem Likely in Japan, Singapore, Australia

2026-04-01 22:00; UTC

Svarbiausios naujienos

DBS Chief Economist: BOK Could Also Take Proactive Approach Like RBA

2026-04-01 22:00; UTC

Svarbiausios naujienos

DBS Chief Economist: India Vulnerable to War Imapct on Both Trade, Energy

2026-04-01 22:00; UTC

Svarbiausios naujienos

DBS Chief Economist: China, Malaysia Looks Relatively Well-Insulated From War Fallout

2026-04-01 22:00; UTC

Svarbiausios naujienos

DBS Chief Economist: Mideast Crisis Won't Hurt Asia Growth Much, Inflation a Bigger Issue

2026-04-01 22:00; UTC

Svarbiausios naujienos

Inflationary Impact of Mideast Conflict Seems Inevitable, DBS Group Chief Economist Says

2026-04-01 21:56; UTC

Įsigijimai, susijungimai, perėmimai

BHP Completes $4.3 Billion Silver Streaming Agreement With Wheaton Precious Metals

2026-04-01 21:31; UTC

Svarbiausios naujienos

End to Iran War Could Trigger Relief Rally in These 2 Assets -- Barrons.com

2026-04-01 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-04-01 20:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2026-04-01 20:38; UTC

Uždarbis

Why Nike Stock Is in 'Penalty Box' After Earnings Beat -- Barrons.com

2026-04-01 20:31; UTC

Įsigijimai, susijungimai, perėmimai

Arsenal Capital Partners Completes Sale of ATP Adhesive Systems to Henkel

2026-04-01 20:16; UTC

Įsigijimai, susijungimai, perėmimai

Gilead: Tender Offer Extended to Expire at 5 p.m. EDT on April 24 >GILD

2026-04-01 20:16; UTC

Įsigijimai, susijungimai, perėmimai

Gilead: Offer Remains at a Purchase Price of $115.00 per Shr >GILD

2026-04-01 20:13; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Extends Tender Offer To Acquire Arcellx >GILD

2026-04-01 20:07; UTC

Rinkos pokalbiai

Mexican Manufacturing Indexes Pick Up in March -- Market Talk

2026-04-01 20:07; UTC

Įsigijimai, susijungimai, perėmimai

Why 2026 Is Biotech's Comeback Year -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Guardant Health Inc Prognozė

Kainos tikslas

By TipRanks

43.68% į viršų

12 mėnesių prognozė

Vidutinis 132.72 USD  43.68%

Aukščiausias 175 USD

Žemiausias 110 USD

Remiantis 20 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Guardant Health Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

20 ratings

19

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

38.86 / 47.41Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bearish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Bullish Evidence

Rinkos nuotaikos

By Acuity

163 / 349 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Vidutinis

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Guardant Health Inc

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research; and with ConcertAI to form first data-as-a-service that integrates clinical and tumor profiling data to accelerate cancer therapy research and development. The company was incorporated in 2011 and is headquartered in Palo Alto, California.
help-icon Live chat